Olusegun Ayo Ade-adekunle

Mr. Olusegun Ayo Ade-adekunle

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2024 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
Olusegun Ayo Ade-adekunleOlusegun Ayo Ade-adekunle
Olusegun Ayo Ade-adekunle
FAFeranmi Olalekan Adekunle
Feranmi Olalekan Adekunle
ZIZulaikha Omayoza Idris
Zulaikha Omayoza Idris
DBDavid Gbenga Babalola
David Gbenga Babalola

29 July 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
OBOluwafemi Bakare
Oluwafemi Bakare
DODaniel Ocha Onwu
Daniel Ocha Onwu
TSToheeb Ayodeji Sodiq
Toheeb Ayodeji Sodiq
OOOnyeka Benjamin Onyeukwu
Onyeka Benjamin Onyeukwu
ALAbdulwarith Olatunji Lawal
Abdulwarith Olatunji Lawal
Olusegun Ayo Ade-adekunleOlusegun Ayo Ade-adekunle
Olusegun Ayo Ade-adekunle
Lassa fever (LF) is a zoonotic viral hemorrhagic disease endemic in West Africa, particularly Nigeria, where recurrent outbreaks continue to pose significant public health challenges. The limited availability of effective antiviral therapies necessitates the identification of repurposable drugs capable of inhibiting viral replication and modulating host molecular targets involved in LF pathogenesis. This study employed an integrated computational drug-repurposing strategy targeting Lassa virus nucleoprotein (NP) and inosine monophosphate dehydrogenase (IMPDH) using network pharmacology, Density Functional Theory (DFT), molecular docking, and molecular dynamics simulations (MDs). Chemical structures of eragidomide, remdesivir, and sofosbuvir were retrieved from the PubChem database, and potential targets were predicted using SwissTargetPrediction. LF-associated genes were obtained from GeneCards, DisGeNET, OMIM, and MalaCards databases, while overlapping targets were identified using Venny 2.1.0. Protein–protein interaction networks were constructed using STRING and visualized in Cytoscape, followed by functional enrichment analysis using the ShinyGO platform. Molecular docking and visualization were performed using BIOVIA Discovery Studio, UCSF Chimera, and PyRx, while Maestro software was used for MM-GBSA binding free-energy calculations and pharmacophore modeling. Docking results demonstrated strong binding interactions with NP and IMPDH, with eragidomide showing the highest affinity toward NP (-11.3 kcal/mol) and favorable interaction with IMPDH (-9.0 kcal/mol). MD simulations conducted over 100 ns indicated stable binding within NP, IMPDH, and EGFR complexes. DFT calculations yielded a total electronic energy of -1973.853045 Eh with an RMS gradient norm of 0.000003 Eh/a₀, confirming optimized and stable molecular geometry of eragidomide. These findings suggest eragidomide as a promising multi-target antiviral candidate against LF replication and host signaling pathways.

29 August 2023 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
Olusegun Ayo Ade-adekunleOlusegun Ayo Ade-adekunle
Olusegun Ayo Ade-adekunle
AOAlaka Hassan Olayemi
Alaka Hassan Olayemi

31 July 2025 in The Journal of Phytopharmacology
Verified
Journal Article
Open access
OOOlufemi Lionel Okunye
Olufemi Lionel Okunye
KCKotun Bunmi Comfort
Kotun Bunmi Comfort
OEOyinloye Oladapo Elijah
Oyinloye Oladapo Elijah
OBOlufunke Caroline Babalola
Olufunke Caroline Babalola
BCBrenda Iloka Chijioke
Brenda Iloka Chijioke
CECoker Morenike Eunice
Coker Morenike Eunice
Background: In folklore, Nigella sativa and Moringa oleifera seeds have long been associated with multifaceted antimicrobial properties, although without extensive empirical scientific validation. Natural products of plant origin have been recognized as potential sources of antimicrobial agents. The antibacterial activity of Moringa oleifera and Nigella sativa against clinical isolates of Staphylococcus aureus has been previously reported in contexts other than burn infections. Objective: This study aimed to compare the antimicrobial effects of Nigella sativa seed and Moringa oleifera seed extracts with gentamicin against Staphylococcus aureus isolates from burn wound infections. The investigation was inspired by ethnobotanical surveys, ethnopharmacological records, and traditional medicinal claims regarding the therapeutic potential of these plants. Materials and Methods: Staphylococcus aureus isolates from burn wound infections were exposed to varying concentrations of Moringa oleifera and Nigella sativa seed extracts (5 µg/mL, 2.5 µg/mL, and 1.25 µg/mL), prepared via cold maceration. Gentamicin at 5 µg/mL served as the standard antibiotic control. All preparations were incubated at 37°C for 24 hours, and antimicrobial activity was assessed by measuring the zone of growth inhibition. Results: Both aqueous and methanol extracts of Moringa oleifera and Nigella sativa seeds demonstrated anti-staphylococcal activity at concentrations ranging from 5 µg/mL to 1.25 µg/mL, particularly at dilution factors of 1:2 to 1:4. However, antimicrobial activity diminished at higher dilutions (1:16 and 1:32). Notably, Nigella sativa seed extract exhibited more pronounced anti-staphylococcal effects than Moringa oleifera. Gentamicin, a broad-spectrum aminoglycoside antibiotic, displayed 100% anti-staphylococcal activity at all tested dilutions. Conclusion: Methanol extracts of Moringa oleifera and Nigella sativa seeds exhibit promising anti-staphylococcal activity and may hold potential for clinical applications as alternative therapies. Gentamicin remains a highly effective standard treatment for Staphylococcus aureus infections, including those associated with burn wounds.